Advertisement
Advertisement

HIV Care Today


"Supersized Alcopops": The Dangers of Excessive Alcohol Consumption for People Living With HIV
By David Fawcett, Ph.D., L.C.S.W.
October 27, 2011

Public apprehension about recreational drugs, especially those that impact HIV, seems to come in waves that swell with increasing alarm and then peak and fade away, always to be replaced by the next "drug du jour." Heroin, cocaine, and methamphetamine, each with a well-deserved reputation for putting people at risk for HIV or, if HIV positive, for interfering with their ability to properly manage their health, have all gained notoriety in recent years.

Read more …


Going, Going, Gone ... HIV Treatment Failure Is Disappearing in People Who Take Their Meds
By Paul E. Sax, M.D.
October 19, 2011

World Series time, hence the baseball reference in the title. (Doesn't take much.) But over in Lancet Infectious Diseases -- which has turned out to be a terrific journal, by the way -- there's a study reminding us that advances in HIV treatment in the late 2000s were truly spectacular.

Read more …


Addressing Mature, Adult Patients During an Initial Interview
By Bethsheba Johnson, G.N.P.-B.C., A.A.H.I.V.S.
October 7, 2011

Introducing yourself to an older adult as a health care provider requires being sensitive to generational issues. It is not appropriate to address clients by their given or first name without requesting their express permission to do so.

Read more …


Spanish HIV Vaccine Story Gets Lots of Attention -- Here's Why
By Paul E. Sax, M.D.
October 4, 2011

If you're looking for a good way to pass the time while running errands, traveling, or walking to work, I highly recommend the Freakonomics podcasts, which have taught me all sorts of interesting things.

Read more …


CASCADE: When to Start, (Yet) Another Take
By Paul E. Sax, M.D.
October 3, 2011

As we await the enrollment, analysis, and results of the START study -- which is randomizing patients with CD4>500 to start HIV therapy vs waiting until the CD4 falls to 350 -- much of the research on "when to start" ART in patients with high CD4's comes from observational studies. Several have already been published (NA-ACCORD, ART-CC, CAUSAL), but one limitation of each of them is that none could accurately assess duration of HIV infection.

Read more …


Where Are the DHHS HIV Treatment Guidelines for Clients Over 50 Years Old?
By Bethsheba Johnson, G.N.P.-B.C., A.A.H.I.V.S.
October 3, 2011

As I just celebrated another birthday and relocated to Houston, Texas, to a nice home with lots and lots of stairs, I couldn't help but think about aging. My knees and back are aching. I'm just plain tired! I know that in the clinical setting you are hearing similar complaints among your older clients. We can be an achy mess as we age! For our clients, is it the untreated/inadequately treated HIV, aging, or both?

Read more …


Warning: Viral Replication Is Hazardous to Your Health
By Paul E. Sax, M.D.
September 24, 2011

When studies evaluate the prognostic importance of measuring HIV viral load, they generally do so by assessing a single measurement rather than values obtained longitudinally. One obvious limitation of this approach is that baseline VL poorly predicts outcome after ART initiation -- a finding in stark contrast to the original description of VL from the MACS cohort prior to effective HIV therapy.

Read more …


"Novel" Approaches to Initial HIV Therapy
By Paul E. Sax, M.D.
September 6, 2011

It's been several years since the "preferred" or "recommended" initial regimens for HIV treatment have been consolidated into one of the following four:

Read more …


Addressing the Gaping Hole in HIV Prevention: A Plea for Public Health Action
By Lisa Fitzpatrick, M.D., M.P.H.
September 6, 2011

The CDC has yet again released a report highlighting the growing HIV disparity in young, black men who have sex with men (MSM). Over a decade ago, similar attention was called to what then appeared to be a public health blemish in this population. Because our prevention efforts have been largely cosmetic and woefully inadequate, the 7% increase in the infection rate among black MSM suggests this blemish is now a gushing and gaping wound requiring urgent public health action.

Read more …


A "Gut Feeling" Emerges in HIV
By Nelson Vergel, B.S.Ch.E., M.B.A.
September 6, 2011

The effects of HIV and highly active antiretroviral therapy [HAART] on gut health were highlighted recently at the 13th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV in Rome, Italy.

Read more …

 < Prev  |  1  |  …  |  9  |  10  |  11  |  12  |  13  |  …  |  15  |  Next > 

Get email notifications every time HIV Care Today is updated.



This article was provided by TheBodyPRO.com.
 

Advertisement